
SALT LAKE CITY — Allogeneic hematopoietic stem cell transplantation appeared effective for patients with high-risk subtypes of acute lymphoblastic leukemia, according to study results.
More than half of patients achieved long-term survival, results presented at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR showed.
The findings also demonstrated that patients who received timely referral to transplant achieved longer OS and DFS.
“The take-home message for the clinical community definitely is the importance of early referral,” Melhem Solh,